PDF(Pubmed)
Abstract：
UNASSIGNED: Ultrasound-detected breast lesions with probably benign features are a great challenge for clinicians, especially in breasts with dense composition. We aimed to investigate the finding of two radiologic modalities on these lesions.
UNASSIGNED: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the \"suspected\" BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables.
UNASSIGNED: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17-67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3-43) and 9 mm (IQR: 10, range: 4-46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging.
UNASSIGNED: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up.
UNASSIGNED: This retrospective cross-sectional study recruited patients including (1) candidates of assisted reproductive therapy (ART), (2) patients with prior high-risk lesions, and (3) the \"suspected\" BIRADS-3 masses referring to masses that US BIRADS-3 was not compatible with the clinical breast exam. The degree of agreement in diagnosing BIRADS-3 lesions between two modalities of magnetic resonance imaging (MRI) and ultrasonography (US), and comparison of the lesions in US and MRI were the study variables.
UNASSIGNED: A total number of 123 lesions in 67 patients with a median age of 38 (IQR: 11, range: 17-67). In the examination by MRI, 107 (87.0 %) lesions were BIRADS-3 indicating the agreement level between these two modalities. The median size of the lesions in US was 9 mm (IQR: 5, range: 3-43) and 9 mm (IQR: 10, range: 4-46) in MRI. The measured size of the lesions between the two modalities was highly correlated (Spearman correlation coefficient: 0.889, P-value < 0.001). MRI evaluation revealed two cases of deep lesions which were missed in the US imaging.
UNASSIGNED: This study found relatively high agreement values between US and MRI in detecting BIRADS-3 breast lesions in candidates for ART or patients with prior high-risk lesions. Also, MRI could downgrade about one-tenth of the cases to a lower BIRADS level and resolved the need for closer follow-up.
摘要：
未经证实：超声检测到的具有可能良性特征的乳腺病变对临床医生来说是一个巨大的挑战，尤其是在成分密集的乳房中。我们旨在调查这些病变上两种放射学方式的发现。
UASSIGNED：这项回顾性横断面研究招募了包括（1）辅助生殖治疗（ART）候选人在内的患者，（2）既往有高危病变的患者，（3）“可疑”BIRADS-3肿块是指USBIRADS-3与临床乳腺检查不兼容的肿块。磁共振成像（MRI）和超声检查（US）两种模式诊断BIRADS-3病变的一致性程度，US和MRI病灶的比较是研究变量。
UNASSIGNED：67例中位年龄38（IQR：11，范围：17-67）患者的123个病灶总数。在核磁共振检查中，BIRADS-3为107例（87.0％）病变，表明这两种方式之间的一致性水平。在MRI中，US中病变的中位大小为9mm（IQR：5，范围：3-43）和9mm（IQR：10，范围：4-46）。两种模式之间测得的病变大小高度相关（Spearman相关系数：0.889，P值<0.001）。MRI评估显示有2例深部病变在US成像中遗漏。
UNASSIGNED：这项研究发现，在ART候选患者或先前有高危病变的患者中，US和MRI在检测BIRADS-3乳腺病变方面具有相对较高的一致性值。此外，MRI可以将大约十分之一的病例降级到较低的BIRADS水平，并解决了对更密切随访的需要。
UASSIGNED：这项回顾性横断面研究招募了包括（1）辅助生殖治疗（ART）候选人在内的患者，（2）既往有高危病变的患者，（3）“可疑”BIRADS-3肿块是指USBIRADS-3与临床乳腺检查不兼容的肿块。磁共振成像（MRI）和超声检查（US）两种模式诊断BIRADS-3病变的一致性程度，US和MRI病灶的比较是研究变量。
UNASSIGNED：67例中位年龄38（IQR：11，范围：17-67）患者的123个病灶总数。在核磁共振检查中，BIRADS-3为107例（87.0％）病变，表明这两种方式之间的一致性水平。在MRI中，US中病变的中位大小为9mm（IQR：5，范围：3-43）和9mm（IQR：10，范围：4-46）。两种模式之间测得的病变大小高度相关（Spearman相关系数：0.889，P值<0.001）。MRI评估显示有2例深部病变在US成像中遗漏。
UNASSIGNED：这项研究发现，在ART候选患者或先前有高危病变的患者中，US和MRI在检测BIRADS-3乳腺病变方面具有相对较高的一致性值。此外，MRI可以将大约十分之一的病例降级到较低的BIRADS水平，并解决了对更密切随访的需要。
